Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model*-Reference-Cited by-同舟云学术

Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model*

Published:2013-01-10 Issue:2 Volume:57 Page:566-576
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Aparicio-Vergara Marcela,Hommelberg Pascal P.H.,Schreurs Marijke,Gruben Nanda,Stienstra Rinke,Shiri-Sverdlov Ronit,Kloosterhuis Niels J.,de Bruin Alain,van de Sluis Bart,Koonen Debby P.Y.,Hofker Marten H.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26046/fullpdf

Reference41 articles.

1. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome;Marchesini;HEPATOLOGY,2003

2. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis;Anderson;Pharmacol Rev,2008

3. Human fatty liver disease: old questions and new insights;Cohen;Science,2011

4. Cytokines in alcoholic and nonalcoholic steatohepatitis;Tilg;N Engl J Med,2000

5. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?;Hui;HEPATOLOGY,2004

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease;Frontiers in Bioscience-Landmark;2024-01-19

2. Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation;EMBO Molecular Medicine;2023-06-26

3. Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis;Journal of Gastroenterology and Hepatology;2021-07-30

4. Immune control of Mycobacterium tuberculosis is dependent on both soluble TNFRp55 and soluble TNFRp75;Immunology;2021-07-08

5. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease;Computers in Biology and Medicine;2021-04